宫颈癌放疗时保留卵巢功能的研究进展  

Research advances in preservation of ovarian function during radiotherapy for cervical carcinoma

作　　者：吕晓娟[1] 程晓龙[1] 俞华[1] 

机构地区：[1]浙江省肿瘤医院妇瘤科,杭州310022

出　　处：《中华放射肿瘤学杂志》2016年第6期661-664,共4页Chinese Journal of Radiation Oncology

摘　　要：目前国内外研究报道均提示移位卵巢放疗后成功保留内分泌功能概率不高。宫颈癌放疗后卵巢功能与多种因素相关,如放疗剂量和方式、患者年龄、移位位置、同期化疗药物。因此对不同患者来说,放疗时需要控制卵巢组织在个体化剂量限制内才可能更加有效保留卵巢功能。At present, reports at home and abroad suggest a low probability of successful preservation of ovarian endocrine function after ovarian shift radiotherapy. After radiotherapy for cervical carcinoma, the ovarian function is associated with various factors, such as radiotherapy dose and method, patient′s age, shift position, and concurrent chemotherapy drugs. Therefore, as for each patient, the dose to the ovarian tissue should be controlled within the individual dose limit to effectively preserve the ovarian function.

关 键 词：宫颈肿瘤/放射疗法 卵巢功能 卵巢保护 

分 类 号：R737.33[医药卫生—肿瘤]